Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.

Thomas KS, Ormerod AD, Craig FE, Greenlaw N, Norrie J, Mitchell E, Mason JM, Johnston GA, Wahie S, Williams HC; UK Dermatology Clinical Trials Network's STOP GAP Team..

J Am Acad Dermatol. 2016 Nov;75(5):940-949. doi: 10.1016/j.jaad.2016.06.016.

PMID:
27502313
2.

Hidradenitis suppurativa and the metabolic syndrome.

Veysey EC.

Br J Dermatol. 2015 Aug;173(2):325-6. doi: 10.1111/bjd.13902. No abstract available.

PMID:
26346081
3.

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team..

BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958.

4.

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.

Chalmers JR, Wojnarowska F, Kirtschig G, Nunn AJ, Bratton DJ, Mason J, Foster KA, Whitham D, Williams HC; BLISTER study group..

Br J Dermatol. 2015 Jul;173(1):227-34. doi: 10.1111/bjd.13729.

PMID:
25683592
5.

UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.

Craig FF, Thomas KS, Mitchell EJ, Williams HC, Norrie J, Mason JM, Ormerod AD; UK Dermatology Clinical Trials Network’s STOP GAP Trial Team..

Trials. 2012 Apr 28;13:51.

6.

A novel missense mutation in GJB2, p.Tyr65His, causes severe Vohwinkel syndrome.

de Zwart-Storm EA, van Geel M, Veysey E, Burge S, Cooper S, Steijlen PM, Martin PE, van Steensel MA.

Br J Dermatol. 2011 Jan;164(1):197-9. doi: 10.1111/j.1365-2133.2010.10058.x.

PMID:
20854437
7.

A survey of sun protection in schools in South Wales.

Grange B, Veysey EC, Morris M, Roberts DL.

Br J Dermatol. 2010 Feb 1;162(2):454-5. doi: 10.1111/j.1365-2133.2009.09559.x. No abstract available.

PMID:
19919629
8.
9.

A lesion on the scalp.

Veysey EC, Coutts I.

Clin Exp Dermatol. 2007 Nov;32(6):775-6. No abstract available.

PMID:
17953646
10.

Consort contact dermatitis to paraphenylenediamine, with an unusual clinical presentation of tumid plaques.

Veysey EC, Burge S, Cooper S.

Contact Dermatitis. 2007 Jun;56(6):366-7. No abstract available.

PMID:
17577386
11.

Photoallergic contact cheilitis due to oxybenzone found in a lip cosmetic.

Veysey EC, Orton DI.

Contact Dermatitis. 2006 Jul;55(1):54. No abstract available.

PMID:
16842557
12.

Actinic folliculitis.

Veysey EC, George S.

Clin Exp Dermatol. 2005 Nov;30(6):659-61.

PMID:
16197382
13.

Facial acanthosis nigricans associated with obesity.

Veysey E, Ratnavel R.

Clin Exp Dermatol. 2005 Jul;30(4):437-9. No abstract available.

PMID:
15953092
14.

Adverse side-effects following attempted removal of tattoos using a non-laser method.

Veysey E, Downs AM.

Br J Dermatol. 2004 Apr;150(4):770-1. No abstract available.

PMID:
15099379
Items per page

Supplemental Content

Loading ...
Support Center